Literature DB >> 29104066

Chlorhexidine sustained-release varnishes for catheter coating - Dissolution kinetics and antibiofilm properties.

Julia Gefter Shenderovich1, Batya Zaks2, David Kirmayer3, Eran Lavy4, Doron Steinberg2, Michael Friedman3.   

Abstract

Catheter-associated urinary tract infections are difficult to eradicate or prevent, due to their biofilm-related nature. Chlorhexidine, a widely used antiseptic, was previously found to be effective against catheter-related biofilms. For the present study, we developed sustained-release chlorhexidine varnishes for catheter coating and evaluated their antibiofilm properties and chlorhexidine-dissolution kinetics under various conditions. The varnishes were based on ethylcellulose or ammonio methacrylate copolymer type A (Eudragit® RL). Chlorhexidine was released by diffusion from a heterogeneous matrix in the case of the ethylcellulose-based formulation, and from a homogeneous matrix in the case of Eudragit® RL. This dictated the release pattern of chlorhexidine under testing conditions: from film specimens, and from coated catheters in a static or flow-through system. Momentary saturation was observed with the flow-through system in Eudragit® RL-based coatings, an effect that might be present in vivo with other formulations as well. The coatings were retained on the catheters for at least 2weeks, and showed prolonged activity in a biological medium, including an antibiofilm effect against Pseudomonas aeruginosa. The current study demonstrates the potential of catheter coatings with sustained release of chlorhexidine in the prevention of catheter-associated urinary tract infections.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiofilm; Catheter-associated infection; Chlorhexidine; Dissolution testing; Sustained release; Varnish

Mesh:

Substances:

Year:  2017        PMID: 29104066     DOI: 10.1016/j.ejps.2017.10.041

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  3 in total

1.  Efficacy and potential use of novel sustained release fillers as intracanal medicaments against Enterococcus faecalis biofilm in vitro.

Authors:  Bernhard Funk; David Kirmayer; Sharonit Sahar-Heft; Irith Gati; Michael Friedman; Doron Steinberg
Journal:  BMC Oral Health       Date:  2019-08-20       Impact factor: 2.757

2.  Carbamazepine Gel Formulation as a Sustained Release Epilepsy Medication for Pediatric Use.

Authors:  Saeid Mezail Mawazi; Sinan Mohammed Abdullah Al-Mahmood; Bappaditya Chatterjee; Hazrina Ab Hadi; Abd Almonem Doolaanea
Journal:  Pharmaceutics       Date:  2019-09-20       Impact factor: 6.321

3.  Voice Prosthesis Coated with Sustained Release Varnish Containing Clotrimazole Shows Long-Term Protection against Candida albicans: An In Vitro Study.

Authors:  Ronit Vogt Sionov; Irith Gati; David Kirmayer; Michael Friedman; Doron Steinberg; Menachem Gross
Journal:  Molecules       Date:  2021-09-05       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.